Senate Appropriators Ask USDA To Remove Business ‘Roadblocks’ In Hemp Production Rule
Executive Summary
Senate committee “is concerned” USDA's interim final rule “creates roadblocks for farmers” by imposing short timeframes for testing harvested hemp for levels of THC in crops and requiring testing only by DEA-registered labs.
You may also be interested in...
Temporary Funding For US Agencies Delays $5M For FDA’s Cannabidiols Regulatory Pathway Work
Senate on 29 September was expected to a pass a CR the House passed a week earlier to fund FDA and other federal departments and agencies through 11 December.
US Bill For CBD Supplement Path Draws Mixed Industry Response
Four major trade organizations applauded the introduction of HR 8179, which would remove statutory impediments to CBD’s lawful use in dietary supplements, subjecting CBD to the same requirements in place for any new dietary ingredient. The Natural Products Association, on the other hand, is calling the bill a misstep.
Unpublished And Under Review? US FDA’s CBD Policy Draft Guidance Still Has Industry Talking
Supplements containing hemp-derived cannabidiols aren’t typical products subject to FDA’s regulatory oversight, and the document stating its thinking on enforcement in the market submitted to the Office of Management and Budget isn’t a typical draft guidance.